Author

Teoman Ozturk

InsermORCID 0009-0007-0010-7042Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

Frédéric RelaixiD· 2 shared Nathalie DidieriD· 2 shared Andrea Carlier· 1 shared Frédéric AuradeiD· 1 shared Hélène RouardiD· 1 shared Inès BarthélémyiD· 1 shared Isabel PunzóniD· 1 shared Jordan Mecca· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

Frédéric RelaixORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PathologyBrainPeer-reviewedFeb 5, 2026

Targeted-SMN insufficiency in Skeletal Muscle Stem Cells mediates non-cell autonomous loss of motor neurons at long term

Jordan Mecca, Julien Mignot, Marianne Gervais…·Nathalie Didier

This study shows that SMN insufficiency in muscle stem cells leads to long-term motor neuron loss through non-cell autonomous mechanisms in SMA.

4 citationstop 2%

mousebulk RNA-seq

𝕏 PostBluesky

Molecular BiologybioRxivPreprintSep 5, 2025

CRISPR/Cas13-mediated Dynamin 2 reduction therapy in a canine model of DNM2-related centronuclear myopathy

Andrea Carlier, Inès Barthélémy, Nicolas Blanchard‐Gutton…·Isabel Punzón

This study demonstrates that CRISPR/Cas13-mediated reduction of DNM2 expression can alleviate CNM symptoms in a canine model.

DOI 10.1101/2025.09.05.672814

experimental assaydrug response / drug discovery

𝕏 PostBluesky